Apac
  • Home
  • CXO Insights
  • CIO Views
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • About us
Apac
  • Admired Tech

    Agile

    AI Healthcare

    Artificial Intelligence

    Augmented Reality

    Aviation

    Big Data

    Blockchain

    Cloud

    Cryptocurrency

    Cyber Security

    Digital Transformation

    Drone

    HPC

    Infrared

    Internet of Things

    Networking

    PropTech

    Remote Work

    Scheduling Software

    Simulation

    Startup

    Storage

    Wireless

  • Banking

    E-Commerce

    Education

    FinTech

    Food and Beverages

    Healthcare

    Insurance

    Legal

    Manufacturing

    Pharma and Life Science

    Retail

    Travel and Hospitality

  • CISCO

    Microsoft

    Oracle

    Salesforce

    SAP

    ServiceNow

  • Business Intelligence

    CEM

    Cloud-based Planning

    Cognitive

    Compliance

    Contact Center

    Contact Tracing

    Contactless Payments

    Corporate Finance

    CRM

    Custom Software Development

    Data Center

    Enterprise Architecture

    Enterprise Communications

    Enterprise Contract Management

    Field Service

    HR Technology

    IT Service Management

    Procurement

    Product Management

    RegTech

    Revenue Management

Menu
    • CISCO
    • Collaboration
    • Compliance
    • Contact Center
    • Healthcare
    • IT Service Management
    • Microsoft
    • Retail
    • MORE
    #

    Apac CIO Outlook Weekly Brief

    ×

    Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Apac CIO Outlook

    Subscribe

    loading

    THANK YOU FOR SUBSCRIBING

    • Home
    • News
    • Biotech
    Editor's Pick (1 - 4 of 8)
    left
    Framework of Three Horizons to Manage Current and Future Growth

    Clark Golestani, VP & CIO, Merck

    The Changing Role of CIO in the Biopharmaceutical Industry

    Andy Newsom, CIO, CSL Behring

    Formula Five For Biotech IT

    Jeffrey Keisling, CIO and SVP, Pfizer

    Finding Answers in R&D Data is a Team Sport

    Dan Hausman,

    Plant Biotechnology Success Requires Collaboration, Proactive Strategy

    Tim Hassinger, President and CEO, Dow AgroSciences

    The Biotech IT PMO 2.0

    Paul Ritchie,

    The Biotech CIO Roadmap in a Sea of Change

    Amit Shah, VP of IT- Enterprise Applications & Systems, Excelitas Technologies

    The Internet of Things in Healthcare:Smart Strategies to Deliver Better Value

    Miguel Louzan, VP-IT, UCB, Inc.

    right

    Seegene and Hologic Collaborate to Offer Real-Time PCR Reagents

    By apacciooutlook | Monday, December 03, 2018

    Tweet
    content-image

    SEOUL: Seegene- a developer of multiplex molecular technologies and multiplex clinical molecular diagnostics- announces its collaboration agreement with Hologic- a manufacturer and supplier of diagnostic products, medical imaging systems and surgical products- to promote and supply high multiplex real-time PCR (Polymerase Chain Reaction) reagents.

    Seegene is manufacturing multiplex assays based on DPO (Dual Priming Oligonucleotide), TOCE, and MuDT (Multiple Detection Temperatures) technologies for the upcoming Hologic Panther Fusion system- the next generation molecular diagnostics platform. MuDT technology provides perfection of qPCR technology by simultaneously identifying and quantifying multipletargets in a single fluorescence channel. Panther Fusion system is a fully automated sample-to-answer instrument, which automates all aspects of nucleic acid testing on a single, integrated platform, eliminating the need for batch processing.

    The collaboration aims to provide laboratory customers a perfect evolution of their Panther system and allow expanded assay menu with real-time PCR capabilities in a single-unit-dose format. Seegene's multiplex reagents will enable simultaneous detection and quantification of various target genes, while Hologic will obtain worldwide commercialization rights to the assays.

    "Our agreement with Hologic represents another meaningful milestone to Seegene's global expansion initiatives in the molecular diagnostics market. We expect to accelerate technological standardization in the MDx market by building up capabilities of assay development applying on various platforms,” says Dr. Jong - Yoon Chun, Founder and CEO, Seegene.

    Weekly Brief

    loading
    ON THE DECK

    Content Management System 2020

    Top Vendors

    Contactless Payments 2020

    Top Vendors

    Admired Tech 2020

    Top Vendors

    Previous Next

    I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

    Read Also

    Four Security Issues in IoT

    Four Security Issues in IoT

    Four Use Cases of AR/VR Technology in Employee Training

    Four Use Cases of AR/VR Technology in Employee Training

    Five Major Trends in Digital Transformation for Businesses

    Five Major Trends in Digital Transformation for Businesses

    How Blockchain Reinvents Regtech

    How Blockchain Reinvents Regtech

    Five AI Technologies to Help Boost Business

    Five AI Technologies to Help Boost Business

    Popular E-Commerce Growth Trends in 2021

    Popular E-Commerce Growth Trends in 2021

    Loading...

    Copyright © 2021 APAC CIOoutlook. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy Policy  |  Sitemap |  Subscribe

    follow on linkedinfollow on twitter follow on rss
    This content is copyright protected

    However, if you would like to share the information in this article, you may use the link below:

    https://www.apacciooutlook.com/news/seegene-and-hologic-collaborate-to-offer-realtime-pcr-reagents-nwid-3333.html